Entera Bio Ltd.
ENTXNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $139.75M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.91$4.20
- Volume (live)
- -
- Avg. volume (3M)
- 583.70K
Entera Bio (ENTX) Stock Price & Financial Analysis
Entera Bio Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.62 - $2.75 |
|---|---|
| 52-Week High | $4.20 |
| 52-Week Low | $0.91 |
| Open | $2.72 |
| Volume (last close) | 572.83K |
| Average Volume (3M) | 583.70K |
| 50-Day MA | $2.89 |
|---|---|
| 200-Day MA | $1.83 |
| 1-Year Change | +17.87% |
| Market Cap | 139.75M |
|---|---|
| Shares Outstanding | 50.45M |
| Price to Book (P/B) | 19.23 |
| EV/EBITDA | -8.99 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Entera Bio at a Glance
As of the Oct 16, 2026 close, Entera Bio (ENTX) has a market capitalization of $139.75M. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $11.31M in cash and securities against $425.00K of debt, a net cash position of $10.88M.
Entera Bio does not currently pay a dividend.
The share price is up 17.9% over the past year. At $2.68 (the Oct 16, 2026 close) it sits within its 52-week range of $0.91 to $4.20, above its 200-day moving average of $1.83.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $10.00, 273.1% above the Oct 16, 2026 close.
Frequently Asked Questions About Entera Bio
What is the current stock price for ENTX?
As of the Oct 16, 2026 close, ENTX stock trades at $2.68. The 52-week range is $0.91–$4.20, with a day range of $2.62–$2.75.
What is the P/E ratio for ENTX?
The P/E ratio (Price-to-Earnings) for ENTX is shown in the Key Statistics section. This valuation metric helps compare Entera Bio Ltd. to industry peers.
Does ENTX pay dividends?
Entera Bio does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ENTX?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for ENTX is Buy. The average 12-month price target is $10.00, a 273.1% upside from the Oct 16, 2026 close of $2.68.
What is the market cap of ENTX?
As of the Oct 16, 2026 close, Entera Bio's market capitalization is $135.2M, classifying it as a micro-cap company. Entera Bio operates in the Healthcare sector within the Biotechnology industry.